The Fifth China (Cangzhou) Fine Traditional Chinese Culture Network Film Festival Excellent Films Promotion Evening Celebrates Cinematic Excellence
CANGZHOU, China, Nov. 21, 2024 /PRNewswire/ -- A news report from xinhuanet:
The Fifth China (Cangzhou) Fine Traditional Chinese Culture Network Film Festival Excellent Films Promotion Evening was held at Cangzhou Stadium on the evening of November 18. The event highlighted 52 outstanding film and television productions, offering insights into the creative processes behind each work. The evening was not only a showcase of cinematic excellence but also marked the launch of a new initiative: the roll-out of the first batch of dedicated film sets and locations specifically designed for the production of online films and series.
The festival, centered on the preservation and promotion of China's traditional culture, has become a significant cultural institution in Cangzhou. Since its initiation on June 20, 2024, it has amassed an impressive array of 3,136 works, including 80 streaming movies, 2,989 short films, 53 digital shorts, and The Lion City Impressions Series, a collection of 14 films that together offer a vivid portrayal of the vibrant city of Cangzhou. The collection not only highlights the diversity but also the enhanced quality of submissions compared to previous years.
Traditional culture is akin to a pearl in the sea, with online films and TV shows acting as the vessels that navigate these valuable traditions into the future. Culture only becomes impactful when it is deeply rooted and gains momentum. The films and TV shows selected for this initiative are deeply entrenched in real life, engaging viewers and fostering the creative evolution and innovative growth of China's traditional culture. This strategic approach not only highlights cultural significance but also positions Cangzhou as an emerging economic powerhouse.
The rising tides of the Bohai Sea have shaped a vast and dramatic landscape, while the convergence of nine rivers fosters a fertile land of prosperity. The masterfully crafted Grand Canal has nourished this ancient city, enriching it with a deep cultural heritage. During the promotional event, several sites were designated as the first batch of film locations - Nanchuan Old Street, Cangzhou Garden Expo Park, the China Grand Canal Intangible Cultural Heritage Exhibition Hall, Cangzhou Dahua Industrial Heritage Cultural Area, Nandagang Migratory Bird Habitat, Cangzhou Iron Lion and the Ancient City Ruins Park, Wuqiao Acrobatics World, Xianxian Danqiao, Ancient Government Office of Hejian, MengCun Bajiquan International Training Center, and Huanghua Port Industrial Tourism Scenic Area.
Cangzhou, a city with a cultural lineage that stretches back thousands of years, is rich in historical significance. In recent years, the city has succeeded in transforming its vast cultural resources into high-quality business ventures, converting cultural 'soft power' into robust 'hard support' for economic growth. Since its launch in 2018, the China (Cangzhou) Fine Traditional Chinese Culture Network Film Festival has continually enhanced its offerings and embraced cutting-edge formats. It has earned accolades and widespread acclaim from industry experts and the public alike, significantly boosting its visibility, influence, and appeal as a premier cultural brand.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Cangzhou Hosts Premiere Chinese Cultural Showcase
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
